Tang Kevin C's Form 4 filing
Rain Oncology Inc. · filed Oct 13, 2023
- Accession no.
- 0001209191-23-052788
- Filed
- Oct 13, 2023, 4:57 PM ET
- Trade date
- Oct 11-13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions. Open-market purchases total $279.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tang Kevin CCIK 0001178579 | 10% Owner |
| Tang Capital Partners LPCIK 0001191935 | 10% Owner |
| Tang Capital Management LLCCIK 0001232621 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 11, 2023 | Common Stock | PPurchaseAcquired | +74,812 | $0.97F1 | +$72,567.64 | 3,815,153 | Indirect | |
| Oct 12, 2023 | Common Stock | PPurchaseAcquired | +25,188 | $0.98F3 | +$24,684.24 | 3,840,341 | Indirect | |
| Oct 12, 2023 | Common Stock | PPurchaseAcquired | +52,514 | $0.98F3 | +$51,463.72 | 3,892,855 | Indirect | |
| Oct 13, 2023 | Common Stock | PPurchaseAcquired | +47,486 | $0.99F3 | +$47,011.14 | 3,940,341 | Indirect | |
| Oct 13, 2023 | Common Stock | PPurchaseAcquired | +84,145 | $0.99F4 | +$83,303.55 | 4,024,486 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $0.94 to $0.99. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnote 1, 3 and 4 herein.
Referenced by the price of 1 transaction in Table I.
- F3
These shares were purchased in multiple transactions ranging from $0.96 to $0.99.
Referenced by the price of 3 transactions in Table I.
- F4
These shares were purchased in multiple transactions ranging from $0.98 to $0.99.
Referenced by the price of 1 transaction in Table I.